BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34030920)

  • 41. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study.
    Bertelsen CA; Neuenschwander AU; Jansen JE; Wilhelmsen M; Kirkegaard-Klitbo A; Tenma JR; Bols B; Ingeholm P; Rasmussen LA; Jepsen LV; Iversen ER; Kristensen B; Gögenur I;
    Lancet Oncol; 2015 Feb; 16(2):161-8. PubMed ID: 25555421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncological outcome of carcinomas in the rectosigmoid junction compared to the upper rectum or sigmoid colon - A retrospective cohort study.
    Falch C; Mueller S; Braun M; Gani C; Fend F; Koenigsrainer A; Kirschniak A
    Eur J Surg Oncol; 2019 Nov; 45(11):2037-2044. PubMed ID: 31239157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas.
    Heger U; Sisic L; Nienhüser H; Blank S; Hinz U; Haag GM; Ott K; Ulrich A; Büchler MW; Schmidt T
    Ann Surg Oncol; 2018 Aug; 25(8):2418-2427. PubMed ID: 29855828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre.
    Alzahrani N; Ung L; Valle SJ; Liauw W; Morris DL
    ANZ J Surg; 2017 Nov; 87(11):E167-E172. PubMed ID: 26178318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
    Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
    J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The measured distance between tumor cells and the peritoneal surface predicts the risk of peritoneal metastases and offers an objective means to differentiate between pT3 and pT4a colon cancer.
    Zwanenburg ES; Wisselink DD; Klaver CEL; van der Bilt JDW; Tanis PJ; Snaebjornsson P;
    Mod Pathol; 2022 Dec; 35(12):1991-2001. PubMed ID: 36123540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patients with extensive regional lymph node involvement (pN2) following potentially curative surgery for colorectal cancer are at increased risk for developing peritoneal metastases: a retrospective single-institution study.
    Bhatt A; Bhamre R; Rohila J; Kalikar V; Desouza A; Saklani A
    Colorectal Dis; 2019 Mar; 21(3):287-296. PubMed ID: 30457185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study.
    Honoré C; Goéré D; Messager M; Souadka A; Dumont F; Piessen G; Elias D; Mariette C;
    Eur J Surg Oncol; 2013 Mar; 39(3):235-41. PubMed ID: 23313257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
    An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
    World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stage II colonic adenocarcinoma: a detailed study of pT4N0 with emphasis on peritoneal involvement and the role of tumour budding.
    Canney AL; Kevans D; Wang LM; Hyland JM; Mulcahy HE; O'Donoghue DP; O'Sullivan J; Geraghty R; Sheahan K
    Histopathology; 2012 Sep; 61(3):488-96. PubMed ID: 22463746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histologic features and cytologic techniques that aid pathologic stage assessment of colonic adenocarcinoma.
    Panarelli NC; Schreiner AM; Brandt SM; Shepherd NA; Yantiss RK
    Am J Surg Pathol; 2013 Aug; 37(8):1252-8. PubMed ID: 23774176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histological transformation to signet-ring cell carcinoma in a patient with clinically aggressive poorly differentiated adenocarcinoma of the ascending colon after response to chemotherapy plus cetuximab: a case report.
    Nagano H; Ohyama S; Sato A; Igarashi J; Yamamoto T; Kadoya M; Kobayashi M
    World J Surg Oncol; 2023 Jun; 21(1):172. PubMed ID: 37280577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ordinary colorectal adenocarcinoma vs. primary colorectal signet-ring cell carcinoma: study matched for age, gender, grade, and stage.
    Psathakis D; Schiedeck TH; Krug F; Oevermann E; Kujath P; Bruch HP
    Dis Colon Rectum; 1999 Dec; 42(12):1618-25. PubMed ID: 10613484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites.
    Zhang Y; Ma J; Zhang S; Deng G; Wu X; He J; Pei H; Shen H; Zeng S
    Int J Colorectal Dis; 2015 Sep; 30(9):1173-83. PubMed ID: 26054387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
    Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
    J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study.
    Simkens GA; van Oudheusden TR; Braam HJ; Wiezer MJ; Nienhuijs SW; Rutten HJ; van Ramshorst B; de Hingh IH
    J Surg Oncol; 2016 Apr; 113(5):548-53. PubMed ID: 27110701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
    Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study.
    Kelm M; Schollbach J; Anger F; Wiegering A; Klein I; Germer CT; Schlegel N; Kunzmann V; Löb S
    BMC Cancer; 2021 May; 21(1):490. PubMed ID: 33941104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prophylactic HIPEC in pT4 Colon Tumors: Proactive Approach or Overtreatment?
    Arrizabalaga NB; Navascués JME; Echaniz GE; Ansorena YS; Galán CP; Martín XA; Pardo LV
    Ann Surg Oncol; 2020 Apr; 27(4):1094-1100. PubMed ID: 31664619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.